Yamato, Japan

Masaru Okutsu


Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Kawasaki, JA (1977)
  • Kawaski, JP (1980)
  • Yamato, JP (1982 - 1987)
  • Kawasaki, JP (1978 - 1990)

Company Filing History:


Years Active: 1977-1990

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Masaru Okutsu: Innovator in Pharmaceutical Chemistry

Introduction

Masaru Okutsu is a prominent inventor based in Yamato, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on azulene derivatives. With a total of 8 patents to his name, Okutsu continues to push the boundaries of scientific research and development.

Latest Patents

One of Okutsu's latest patents focuses on azulene derivatives and pharmaceutical compositions containing them. These derivatives are characterized by a specific formula where R¹ represents an alkyl group of 1 to 3 carbon atoms, R² also represents an alkyl group of 1 to 3 carbon atoms, and R³, located at the 5- or 6-position, can be an alkyl group of 1 to 6 carbon atoms, an aryl group of 6 to 9 carbon atoms, or an aralkyl group of 7 to 10 carbon atoms. These compounds exhibit antihyperlipidemic activity, and many of them are considered novel in their own right.

Career Highlights

Masaru Okutsu is affiliated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to explore various innovative avenues in drug development, particularly in the realm of compounds that can positively impact health.

Collaborations

Okutsu has collaborated with notable colleagues such as Naohiko Yasuda and Masabumi Yasunami. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Masaru Okutsu stands out as a key figure in pharmaceutical innovation, with a focus on azulene derivatives that hold promise for medical applications. His contributions continue to shape the landscape of pharmaceutical chemistry and improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…